Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Flinn, Ian W., van der Jagt, Richard, Kahl, Brad S., Wood, Peter, Hawkins, Tim E., MacDonald, David, Hertzberg, Mark, Kwan, Yiu-Lam, Simpson, David, Craig, Michael, Kolibaba, Kathryn, Issa, Samar, Clementi, Regina, Hallman, Doreen M., Munteanu, Mihaela, Chen, Ling, Burke, John M.
Published in Blood (08.05.2014)
Published in Blood (08.05.2014)
Get full text
Journal Article
Retrospective pharmaceutical financial benefits and cost avoidance analysis of clinical trial participation in the Australian haematology setting
Truong, Kelvin, Kwan, Yiu Lam, Nigro, Lucia, Huseincehajic, Admir, Trotman, Judith
Published in Internal medicine journal (01.09.2019)
Published in Internal medicine journal (01.09.2019)
Get full text
Journal Article
Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease
Moran, Neil R, Webster, Bradley, Lee, Kenneth M, Trotman, Judith, Kwan, Yiu-Lam, Napoli, John, Leong, Rupert W
Published in World journal of gastroenterology : WJG (21.05.2015)
Published in World journal of gastroenterology : WJG (21.05.2015)
Get full text
Journal Article
A sensitive method for the detection of poly-A tails of mRNA using a biotin-labelled heteropolymer of dT:rA
Markovic, B, Kwan, Y L, Nicholls, E M, Walsh, C, Crouch, R L
Published in The Journal of pathology (01.08.1992)
Published in The Journal of pathology (01.08.1992)
Get more information
Journal Article
Ex vivo expansion of functional T lymphocytes from HIV-infected individuals
Trickett, Annette E., Kwan, Yiu Lam, Cameron, Barbara, Dwyer, John M.
Published in Journal of immunological methods (01.04.2002)
Published in Journal of immunological methods (01.04.2002)
Get full text
Journal Article
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
Yeung, David T., Osborn, Michael P., White, Deborah L., Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark, Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K., Kwan, Yiu Lam, Trotman, Judith, Forsyth, Cecily J., Taper, John, Ross, David M., Beresford, Jennifer, Tam, Constantine, Mills, Anthony K., Grigg, Andrew P., Hughes, Timothy P.
Published in Blood (05.02.2015)
Published in Blood (05.02.2015)
Get full text
Journal Article
Abstract B45: Multiple myeloma: A novel tailor-made therapeutic management
Krishnan, Sabna Rajeev, Bebawy, Mary, Luk, Frederick, Brown, Ross Duncan, Kwan, Yiu Lam
Published in Clinical cancer research (01.09.2015)
Published in Clinical cancer research (01.09.2015)
Get full text
Journal Article
High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation
Nath, Christa E., Trotman, Judith, Tiley, Campbell, Presgrave, Peter, Joshua, Douglas, Kerridge, Ian, Kwan, Yiu Lam, Gurney, Howard, McLachlan, Andrew J., Earl, John W., Nivison‐Smith, Ian, Zeng, Lihua, Shaw, Peter J.
Published in British journal of clinical pharmacology (01.07.2016)
Published in British journal of clinical pharmacology (01.07.2016)
Get full text
Journal Article
Evaluation of Pharmacokinetic-Based Dose Predictions of High Dose Melphalan in Patients with Myeloma
Trotman, Judith, Shaw, Peter J., Tiley, Campbell, Ramanathan, Sundra, Grigg, Andrew P, Larsen, Stephen Robert, Presgrave, Peter, Kwan, Yiu-Lam, Newman, Elizabeth, Nath, Christa
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy
Nath, Christa E., Shaw, Peter J., Trotman, Judith, Zeng, Lihua, Duffull, Stephen B., Hegarty, Gareth, McLachlan, Andrew J., Gurney, Howard, Kerridge, Ian, Kwan, Yiu Lam, Presgrave, Peter, Tiley, Campbell, Joshua, Douglas, Earl, John
Published in British journal of clinical pharmacology (01.05.2010)
Published in British journal of clinical pharmacology (01.05.2010)
Get full text
Journal Article
Formalising multidisciplinary peer review: developing a haematological malignancy‐specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence‐based clinical practice
Trotman, Judith, Trinh, Jimmy, Kwan, Yiu Lam, Estell, Jane A., Fletcher, Julie, Archer, Kate, Lee, Kenneth, Foo, Kerwin, Curnow, Jennifer, Bianchi, Alessandra, Wignall, Lynda, Verner, Emma, Gasiorowski, Robin, Siedlecka, Elizabeth, Cunningham, Ilona
Published in Internal medicine journal (01.05.2017)
Published in Internal medicine journal (01.05.2017)
Get full text
Journal Article
Upfront Imatinib with Selective Early Switching to Nilotinib Leads to Excellent Achievement of Deep Molecular Response in Chronic Phase CML: 5 Year (Final) Analysis of the TIDEL-II Study
Yeung, David T., Osborn, Michael Philip, White, Deborah L, Branford, Susan, Gerber, Tracey, Butcher, Belinda, Issa, Samar, Hiwase, Devendra K, Hertzberg, Mark S, Gottlieb, David, Schwarer, Anthony P, Filshie, Robin, Arthur, Christopher, Kwan, Yiu-Lam, Forsyth, Cecily, Taper, John, Ross, David M., Tam, Constantine S., Mills, Anthony K., Grigg, Andrew, Hughes, Timothy P.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Lower Drug Exposure Is Related to Renal Function and Results in Inferior Survival: A Pharmacokinetic Study of High Dose Melphalan in Myeloma
Trotman, Judith, Shaw, Peter J., Joshua, Douglas E, Kwan, Yiu-Lam, Tiley, Campbell, Presgrave, Peter, Kerridge, Ian H., Nath, Christa
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Trisomy 4 in a case of acute biphenotypic leukemia
Britton, Vikki, Kwan, Yiu-Lam, White, Les, Yip, Moh-Ying
Published in Cancer genetics and cytogenetics (15.07.1990)
Published in Cancer genetics and cytogenetics (15.07.1990)
Get full text
Journal Article
An Open-Label, Randomized Study of Bendamustine and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in First-Line Treatment of Patients with Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL): The Bright Study
Flinn, Ian W., Van der Jagt, Richard H., Kahl, Brad S., Wood, Peter, Hawkins, Tim E., MacDonald, David, Hertzberg, Mark, Kwan, Yiu-Lam, Simpson, David, Craig, Michael, Kolibaba, Kathryn, Issa, Samar, Munteanu, Mihaela C., Clementi, Regina, Chen, Ling, Burke, John M.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Different safety profiles of first-line bendamustine-rituximab (BR), R-CHOP, and R-CVP in an open-label, randomized study of indolent non-Hodgkin lymphoma (NHL) and mantle cell lymphoma (MCL): The BRIGHT study
MacDonald, David, van der Jagt, Richard, Burke, John M., Kahl, Brad S., Wood, Peter, Hawkins, Tim E., Hertzberg, Mark, Kwan, Yiu-Lam, Simpson, David, Craig, Michael, Kolibaba, Kathryn S., Issa, Samar, Clementi, Regina, Hallman, Doreen M., Munteanu, Mihaela C., Chen, Ling, Flinn, Ian
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Secondary efficacy subanalysis by histology from the phase III BRIGHT study: First-line bendamustine-rituximab (BR) compared with standard R-CHOP/R-CVP for patients with advanced indolent non-Hodgkin lymphoma (NHL) or mantle cell lymphoma (MCL)
Flinn, Ian, Van Der Jagt, Richard H. C., Kahl, Brad S., Wood, Peter, Hawkins, Tim E., MacDonald, David, Hertzberg, Mark, Kwan, Yiu-Lam, Simpson, David, Craig, Michael, Kolibaba, Kathryn S., Issa, Samar, Clementi, Regina, Hallman, Doreen M., Munteanu, Mihaela C., Chen, Ling, Burke, John M.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Early Switch to Nilotinib Does Not Overcome the Adverse Outcome for CML Patients Failing to Achieve Early Molecular Response On Imatinib, Despite Excellent Overall Outcomes in the TIDEL II Trial
Yeung, David T, Osborn, Michael Philip, White, Deborah L, Branford, Susan, Kornhauser, Michael, Slader, Cassandra, Issa, Samar, Hiwase, Devendra K., Hertzberg, Mark S., Schwarer, Anthony P., Filshie, Robin, Arthur, Christopher K, Kwan, Yiu Lam, Forsyth, Cecily J, Ross, David, Mills, Anthony K., Grigg, Andrew, Hughes, Timothy P.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article